150 related articles for article (PubMed ID: 8778949)
21. [Nonspecific immunity factors and elimination of circulating immune complexes in patients with myocardial infarct in the 1st phase of rehabilitation].
Chan G; Osipov SG; Sipatova MA; Soboleva VA; Nikitin AE
Kardiologiia; 1985 Aug; 25(8):35-7. PubMed ID: 4068457
[TBL] [Abstract][Full Text] [Related]
22. Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease.
Calis M; Ates F; Yazici C; Kose K; Kirnap M; Demir M; Borlu M; Evereklioglu C
Rheumatol Int; 2005 Aug; 25(6):452-6. PubMed ID: 15868151
[TBL] [Abstract][Full Text] [Related]
23. Lipoprotein-associated phospholipase A2 level in patients with Behçet's disease.
Örem A; Yayli S; Arıca DA; Akcan B; Yücesan FB; Bahadir S
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e289-93. PubMed ID: 22755553
[TBL] [Abstract][Full Text] [Related]
24. Kawasaki disease: monitoring of circulating immune complexes.
Salo E; Kekomäki R; Pelkonen P; Ruuskanen O; Viander M; Wagner O
Eur J Pediatr; 1988 May; 147(4):377-80. PubMed ID: 3294012
[TBL] [Abstract][Full Text] [Related]
25. Circulating immune complexes in Indian childhood cirrhosis.
Kalra V; Harkiss GD; Lachmann PJ; Ghai OP
Clin Exp Immunol; 1982 Oct; 50(1):1-6. PubMed ID: 6924609
[TBL] [Abstract][Full Text] [Related]
26. Serum oxidant/antioxidant status in patients with Behçet's disease.
Taysi S; Kocer I; Memisogullari R; Kiziltunc A
Ann Clin Lab Sci; 2002; 32(4):377-82. PubMed ID: 12458889
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
[TBL] [Abstract][Full Text] [Related]
28. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
29. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
30. [Circulating immune complex and complement (C3) in a course of pulmonary tuberculosis].
Dubaniewicz A; Sztaba-Kania M
Pol Merkur Lekarski; 2002 Jun; 12(72):491-5. PubMed ID: 12362668
[TBL] [Abstract][Full Text] [Related]
31. [Immune complexes and C3 and C4 of the complement in urine of patients with glomerulonephritis].
Kacprzyk F; Chrzanowski W
Pol Arch Med Wewn; 1996 Sep; 96(3):215-23. PubMed ID: 9122012
[TBL] [Abstract][Full Text] [Related]
32. Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assays.
Krapf F; Fuchs C; Herrmann M; Hoferichter S; Kalden JR
J Clin Lab Immunol; 1986 Dec; 21(4):183-7. PubMed ID: 3550093
[TBL] [Abstract][Full Text] [Related]
33. Circulating immune complexome analysis identified anti-tubulin-α-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet's Disease.
Cheng Y; Zhao X; Chen Y; Li Y; Jia R; Zhu L; Huang C; Sun X; Deng H; Li Z
PLoS One; 2018; 13(6):e0199047. PubMed ID: 29902281
[TBL] [Abstract][Full Text] [Related]
34. Serum endocan levels as a marker of disease activity in patients with Behçet disease.
Balta I; Balta S; Koryurek OM; Demirkol S; Mikhailidis DP; Celik T; Cakar M; Kucuk U; Eksioglu M; Kurt YG
J Am Acad Dermatol; 2014 Feb; 70(2):291-6. PubMed ID: 24176522
[TBL] [Abstract][Full Text] [Related]
35. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus.
Thanadetsuntorn C; Ngamjanyaporn P; Setthaudom C; Hodge K; Saengpiya N; Pisitkun P
Sci Rep; 2018 Feb; 8(1):2620. PubMed ID: 29422675
[TBL] [Abstract][Full Text] [Related]
36. Serum beta 2-microglobulin reflects disease activity in Behçet's disease.
Aygündüz M; Bavbek N; Oztürk M; Kaftan O; Koşar A; Kirazli S
Rheumatol Int; 2002 May; 22(1):5-8. PubMed ID: 12120912
[TBL] [Abstract][Full Text] [Related]
37. Relationship of C3 & C4 levels with filarial immune complexes in bancroftian filariasis.
Prasad GB; Harinath BC
Indian J Med Res; 1989 Sep; 89():322-5. PubMed ID: 2697689
[TBL] [Abstract][Full Text] [Related]
38. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.
Turan B; Gallati H; Erdi H; Gürler A; Michel BA; Villiger PM
J Rheumatol; 1997 Jan; 24(1):128-32. PubMed ID: 9002023
[TBL] [Abstract][Full Text] [Related]
39. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.
Duygulu F; Evereklioglu C; Calis M; Borlu M; Cekmen M; Ascioglu O
Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528
[TBL] [Abstract][Full Text] [Related]
40. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
Clin Exp Rheumatol; 2011; 29(6):1049-56. PubMed ID: 22153664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]